Nkarta
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nkarta and other ETFs, options, and stocks.About NKTX
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells.
NKTX Key Statistics
Stock Snapshot
As of today, Nkarta(NKTX) shares are valued at $2.50. The company's market cap stands at 177.22M, with a P/E ratio of -1.77.
On 2026-03-06, Nkarta(NKTX) stock moved within a range of $2.32 to $2.56. With shares now at $2.50, the stock is trading +7.7% above its intraday low and -2.2% below the session's peak.
Trading volume for Nkarta(NKTX) stock has reached 672.92K, versus its average volume of 826.16K.
The stock's 52-week range extends from a low of $1.31 to a high of $2.81.
The stock's 52-week range extends from a low of $1.31 to a high of $2.81.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.